Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared a post by Jame Abraham, Chairman and Professor at the Department of Hematology and Medical Oncology at Cleveland Clinic, on X, adding:
“Perfectly timed with ESMO Breast 2025, we celebrate the publication of our latest review article on how to test for HER2 expression in the ADC era — just published in JCO Oncology Practice.”
Quoting Jame Abraham‘s post:
“Redefining Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer in the Era of Novel Antibody-Drug Conjugates | JCO Oncology Practice
Excellent article by Paolo Tarantino and colleagues to help us to undestand Her-2 testing now!”
Title: Redefining Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer in the Era of Novel Antibody-Drug Conjugates
Journal: JCO Oncology Practice
Authors: Eleonora Nicolò, Caterina Gianni, and Paolo Tarantino,
More posts featuring Breast Cancer on OncoDaily.
